Why the study?
A suite of quality indicators was needed to evaluate and quantify adherence to guideline-recommended clinical practice and improve outcomes for adults with heart failure.
Answers are grounded in this paper and cite their sources.
The ESC developed 12 main and 4 secondary quality indicators across five domains to quantify and improve adherence to guideline-recommended clinical practice for adults with heart failure.
AIMS: To develop a suite of quality indicators (QIs) for the evaluation of the quality of care for adults with heart failure (HF). METHODS AND RESULTS: We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care for the management of HF by constructing a conceptual framework of HF care, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. The Working Group comprised experts in HF management including Task Force members of the 2021 European Society of Cardiology (ESC) Clinical Practice Guidelines for HF, members of the Heart Failure Association (HFA), Quality Indicator Committee and a patient representative. In total, 12 main and 4 secondary QIs were selected across five domains of care for the management of HF: (1) structural framework, (2) patient assessment, (3) initial treatment, (4) therapy optimization, and (5) assessment of patient health-related quality of life. CONCLUSION: We present the ESC HFA QIs for HF, describe their development process and provide the scientific rationale for their selection. The indicators may be used to quantify and improve adherence to guideline-recommended clinical practice and thus improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Aktaa et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: